These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30371563)

  • 21. Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.
    Bacalbasa N; Dima S; Balescu I; David L; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4099-104. PubMed ID: 26124361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
    Nica A; Covens A; Parra-Herran C; May T
    Gynecol Oncol; 2020 Sep; 158(3):622-630. PubMed ID: 32561124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis.
    Valenti G; Vitagliano A; Morotti M; Giorda G; Sopracordevole F; Sapia F; Lo Presti V; Chiofalo B; Forte S; Lo Presti L; Tozzi R
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():3-15. PubMed ID: 34942555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer.
    Timmermans M; Zwakman N; Sonke GS; Van de Vijver KK; Duk MJ; van der Aa MA; Kruitwagen RF
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():364-369. PubMed ID: 31400565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
    Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.
    Sørensen SM; Schnack TH; Høgdall C
    Acta Obstet Gynecol Scand; 2019 Jan; 98(1):34-43. PubMed ID: 30168853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?
    Mert I; Kumar A; Torres D; Huang Y; McGree ME; Weaver AL; Cliby WA
    Gynecol Oncol; 2019 May; 153(2):238-241. PubMed ID: 30833135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.
    Kim M; Suh DH; Park JY; Paik ES; Lee S; Eoh KJ; Nam JH; Lee YY; Kim JW; Kim S
    J Gynecol Oncol; 2018 Jul; 29(4):e60. PubMed ID: 29770630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI).
    Fotopoulou C; Rinne N; Ghirardi V; Cunnea P; Drosou A; Tzovaras D; Giudice MT; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Oct; 30(10):1562-1568. PubMed ID: 32817201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
    Cai HB; Zhou YF; Chen HZ; Hou HY
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of prognosis and associated factors in multiple recurrent epithelial ovarian cancer with three times or more cytoreductive surgeries].
    Zou RY; Yuan L; Chen M; Yao LQ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Mar; 58(3):198-206. PubMed ID: 36935197
    [No Abstract]   [Full Text] [Related]  

  • 33. Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.
    Lago V; Fotopoulou C; Chiantera V; Minig L; Gil-Moreno A; Cascales-Campos PA; Jurado M; Tejerizo A; Padilla-Iserte P; Malune ME; Di Donna MC; Marina T; Sanchez-Iglesias JL; Chiva L; Olloqui A; Matute L; García-Granero A; Cárdenas-Rebollo JM; Domingo S
    Gynecol Oncol; 2020 Sep; 158(3):603-607. PubMed ID: 32571682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands.
    Timmermans M; Sonke GS; Slangen BFM; Baalbergen A; Bekkers RLM; Fons G; Gerestein CG; Kruse AJ; Roes EM; Zusterzeel PLM; Van de Vijver KK; Kruitwagen RFPM; van der Aa MA
    Eur J Surg Oncol; 2019 Aug; 45(8):1425-1431. PubMed ID: 31027945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer.
    Kim JH; Han WH; Lee DE; Kim SY; You K; Park SS; Lee DW; Seo SS; Kang S; Park SY; Lim MC
    J Ovarian Res; 2023 Apr; 16(1):85. PubMed ID: 37120533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience.
    Babayeva A; Braicu EI; Grabowski JP; Gasimli K; Richter R; Muallem MZ; Sehouli J
    Int J Gynecol Cancer; 2018 Oct; 28(8):1491-1497. PubMed ID: 30095708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
    Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
    Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
    Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
    Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
    Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
    Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.